An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose

Published:2023-04-06 Issue:7 Volume:64 Page:1109-1116
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Brosch-Lenz Julia,Ke Suqi,Wang Hao,Frey Eric,Dewaraja Yuni K.,Sunderland John,Uribe Carlos

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

2. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

3. Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities;Fendler;Clin Cancer Res.,2022

4. Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII;Fiedler;Nucl Med Biol.,2018

5. Bombesin receptors as potential targets for anticancer drug delivery and imaging;Pooja;Int J Biochem Cell Biol.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity;Journal of Nuclear Medicine;2024-07-03

3. Enhancing voxel‐based dosimetry accuracy with an unsupervised deep learning approach for hybrid medical image registration;Medical Physics;2024-05-21

4. Optimization of the number of post-therapeutic planar imaging time points for the most reliable organ and tumour dosimetry in peptide receptor radionuclide therapy;Health and Technology;2024-05-01

5. EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3